Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abivax, Adlai, Afyx, Aligos, Anji, Biolinerx, Biomarin, Chinook, Covis, Ideaya, Immunic, Inflarx, Longeveron, Merck & Co., Novavax, Noxxon, Panbela, Qlaris, Recce, Regenxbio, Regulus, Ridgeback, Roche, SK, Urovant.